Abstract
Non-pharmaceutical interventions (NPIs) to mitigate the spread of SARS-CoV-2 were often implemented under considerable uncertainty and a lack of scientific evidence. Assessing the effectiveness of the individual interventions is critical to inform future preparedness response plans. Here we quantify the impact of 4,579 NPIs implemented in 76 territories on the effective reproduction number, Rt, of COVID-19. We use a hierarchically coded data set of NPIs and propose a novel modelling approach that combines four computational techniques, which together allow for a worldwide consensus rank of the NPIs based on their effectiveness in mitigating the spread of COVID-19. We show how the effectiveness of individual NPIs strongly varies across countries and world regions, and in relation to human and economic development as well as different dimensions of governance. We quantify the effectiveness of each NPI with respect to the epidemic age of its adoption, i.e., how early into the epidemics. The emerging picture is one in which no one-fits-all solution exists, and no single NPI alone can decrease Rt below one and that a combination of NPIs is necessary to curb the spread of the virus. We show that there are NPIs considerably less intrusive and costly than lockdowns that are also highly effective, such as certain risk communication strategies and voluntary measures that strengthen the healthcare system. By allowing to simulate “what-if” scenarios at the country level, our approach opens the way for planning the most likely effectiveness of future NPIs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the Austrian Science Promotion Agency, FFG project under 857136, the WWTF under COV 20-001, COV 20-017 and MA16-045, the Medizinisch-Wissenschaftlichen Fonds des Buergermeisters der Bundeshauptstadt Wien under CoVid004, and the project VET-Austria, a cooperation between the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection, the Austrian Agency for Health and Food Safety and the University of Veterinary Medicine Vienna.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data set on non-pharmaceutical interventions to curb the spread of COVID-19 is available online via the following repository: https://github.com/amel-github/covid19-interventionmeasures. The data on confirmed cases of COVID-19 has been taken from https://github.com/CSSEGISandData/COVID-19.
